GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $251,000 | +1040.9% | 3,694 | +1072.7% | 0.01% | +1000.0% |
| Q1 2019 | $22,000 | 0.0% | 315 | -8.2% | 0.00% | 0.0% |
| Q4 2018 | $22,000 | 0.0% | 343 | +7.2% | 0.00% | 0.0% |
| Q3 2018 | $22,000 | +120.0% | 320 | +60.0% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | +66.7% | 200 | 0.0% | 0.00% | – |
| Q1 2018 | $6,000 | -84.6% | 200 | -83.3% | 0.00% | -100.0% |
| Q3 2017 | $39,000 | -75.0% | 1,200 | -77.4% | 0.00% | -78.9% |
| Q4 2016 | $156,000 | +254.5% | 5,300 | +251.9% | 0.02% | +280.0% |
| Q3 2016 | $44,000 | -50.0% | 1,506 | -55.8% | 0.01% | -58.3% |
| Q2 2016 | $88,000 | +54.4% | 3,406 | +48.1% | 0.01% | +50.0% |
| Q1 2016 | $57,000 | -18.6% | 2,300 | +4.5% | 0.01% | -20.0% |
| Q4 2014 | $70,000 | -1.4% | 2,200 | -12.0% | 0.01% | 0.0% |
| Q3 2014 | $71,000 | +18.3% | 2,500 | +13.6% | 0.01% | +25.0% |
| Q2 2014 | $60,000 | +3.4% | 2,200 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $58,000 | +107.1% | 2,200 | +144.4% | 0.01% | +60.0% |
| Q3 2013 | $28,000 | – | 900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |